Pfizer (PFE) Enters Strategic Research Collaboration & License Agreement with Kineta Immuno-Oncology to Develop New Cancer Immunotherapies

December 17, 2018 8:08 AM
Pfizer Inc. (NYSE: PFE) today announced that it has entered into a strategic research collaboration with Kineta Immuno-Oncology, LLC (KIO) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Management Comments

Next Articles